Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengru Patch
- Development stage
- Phase 2
- Lead developer
- 奇正藏药
- Administration
- Topical
01
Overview
Zhengru Patch is a topical Tibetan medicine developed by Gansu Qizheng Tibetan Medicine for the treatment of mammary gland hyperplasia. It is formulated based on traditional Tibetan medical principles to treat 'Nucuo disease,' which corresponds to the liver-qi stagnation and phlegm coagulation pattern in Traditional Chinese Medicine (TCM). The patch is applied topically to the breast area to alleviate symptoms such as pain and nodules. It has been evaluated in a randomized, double-blind, placebo-controlled Phase 2 clinical trial in China.
- Brand names
- Zhengru Patch
- Other names
- 正乳贴Zhengru Tie
Beyond the preview
Go deeper on Zhengru Patch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhengru Patch.